Clinical trial
Plasma Membrane Antigens as Trigger in Cancer-associated Myositis
NCT06808672 is registered in ClinicalTrials.gov with Azienda USL Reggio Emilia - IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Plasma Membrane Antigens as Trigger in Cancer-associated Myositis
- Lead sponsor
- Azienda USL Reggio Emilia - IRCCS
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 13, 2019
- Completion date
- December 31, 2026
- Enrollment
- 50 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.